LAB Casdin Partners Master Fund L.P. buys $5.1M worth of shares
Mar 27, 2025, 10:32 AM
0.00%
What does LAB do
Standard BioTools, headquartered in South San Francisco, offers biotechnology tools and services for clinical research, focusing on proteomics and genomics with 534 employees since its IPO in 2011. The company provides insights into health and disease using advanced technologies for diverse applications in translational and clinical research.
Casdin Partners Master Fund L.P. bought 4,820,959 shares of LAB on 28 February at $1.06 per share, worth a total of $5.1M. They now own 58,846,780 LAB shares, or a 9% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
